No abstract available
Keywords:
CAR-T cell; Diffuse large B-cell lymphoma; Lisocabtagene maraleucel; Lymphome B diffus à grandes cellules; Rechute; Relapse.
MeSH terms
-
Drug Approval
-
Humans
-
Immunotherapy, Adoptive / adverse effects
-
Lymphoma, Follicular* / drug therapy
-
Lymphoma, Large B-Cell, Diffuse* / drug therapy
-
Lymphoma, Large B-Cell, Diffuse* / pathology
-
Lymphoma, Non-Hodgkin* / drug therapy